Can retelling and deep breathing ease trauma in terminal cancer?
NCT ID NCT03652298
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This Phase 2 trial tested a neuroscience-based technique combining memory structuring and deep vagal breathing to reduce PTSD symptoms in people with advanced, incurable cancer and their partners. The study enrolled 19 patients who had just received a terminal diagnosis. The approach aimed to help them process the traumatic news by organizing memories and using paced breathing to calm the nervous system. The trial was terminated early, so firm conclusions cannot be drawn.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Memory structuring intervention plus vagal breathing
- What this could lead to
- If it works, this could point toward a non-drug technique to reduce PTSD symptoms in people with advanced cancer.
- What could go wrong
- The trial was terminated early with only 19 participants, so results are very limited. It is unclear if the approach is effective or safe in this setting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Oscar Lambret
Lille, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Could deep breaths before surgery ward off Post-Op confusion?
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk